Literature DB >> 113822

Mediation of central prostaglandin effects by serotoninergic neurons.

R Brus, Z S Herman, R Szkilnik, J Zabawska.   

Abstract

Ten days after administration of 5,6-dihydroxytryptamine, which causes degeneration of central serotoninergic neurons, the depressive behavioral effects of PGF2 alpha and PGE2 were evidently inhibited. Central chemical serotoninectomy abolished the hyperthermic and hypertensive effects of PGF2 alpha, but only slightly affected those of PGE2. It is concluded that serotoninergic neurons mediate the depressive behavioral action of both PGF2 alpha and PGE2. They also mediate the hyperthermic and hypertensive action of PGF2 alpha but not of PGE2. This suggests that these prostaglandins have different central modes of action.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 113822     DOI: 10.1007/bf00427355

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  IDENTIFICATION OF A SMOOTH MUSCLE-STIMULATING FACTOR IN BOVINE BRAIN. PROSTAGLANDINS AND RELATED FACTORS 25.

Authors:  B SAMUELSSON
Journal:  Biochim Biophys Acta       Date:  1964-04-20

2.  Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. IV. Influence of haloperidol (R 1625) and of chlorpromazine on the behaviour of rats in an unfamiliar "open field" situation.

Authors:  P A JANSSEN; A H JAGENEAU; K H SCHELLEKENS
Journal:  Psychopharmacologia       Date:  1960-09-13

3.  Central mediated pressor effect by prostaglandins in the rat.

Authors:  D J Rinchuse; R R Deuben
Journal:  Prostaglandins       Date:  1976-03

Review 4.  Prostaglandins and the central nervous system.

Authors:  F Coceani
Journal:  Arch Intern Med       Date:  1974-01

5.  On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.

Authors:  J S Richardson; N Cowan; R Hartman; D M Jacobowitz
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-05

6.  The action of chlorpromazine on exploration in pairs of rats.

Authors:  S E File; J H Pope
Journal:  Psychopharmacologia       Date:  1974-07-11

7.  Increased irritability: a permanent behavior change induced in the rat by intraventricular administration of 6-hydroxydopamine.

Authors:  K Nakamura; H Thoenen
Journal:  Psychopharmacologia       Date:  1972

8.  Body temperature responses at different ambient temperatures following injections of prostaglandin E1 and noradrenaline into the brain.

Authors:  W L Veale; I Q Whishaw
Journal:  Pharmacol Biochem Behav       Date:  1976-02       Impact factor: 3.533

9.  ACTIONS OF PROSTAGLANDINS E1, E2 AND E3 ON THE CENTRAL NERVOUS SYSTEM.

Authors:  E W HORTON
Journal:  Br J Pharmacol Chemother       Date:  1964-02

10.  Fever produced by prostaglandin E1.

Authors:  W Feldberg; P N Saxena
Journal:  J Physiol       Date:  1971-09       Impact factor: 5.182

View more
  4 in total

1.  Role of putative neurotransmitters in the central gastric antisecretory effect of prostaglandin E2 in rats.

Authors:  J Puurunen
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

2.  Effects of intracerebroventricular administration of prostaglandin D2 on behaviour, blood pressure and body temperature as compared to prostaglandins E2 and F2 alpha.

Authors:  U Förstermann; R Heldt; G Hertting
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 3.  Gut-Brain Axis in Gastric Mucosal Damage and Protection.

Authors:  Dolores Sgambato; Annalisa Capuano; Maria Giuseppa Sullo; Agnese Miranda; Alessandro Federico; Marco Romano
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

4.  Lipid mediators in plasma of autism spectrum disorders.

Authors:  Afaf El-Ansary; Laila Al-Ayadhi
Journal:  Lipids Health Dis       Date:  2012-11-21       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.